These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 14988768)

  • 1. Bisphosphonate treatment for multiple myeloma.
    Terpos E; Rahemtulla A
    Drugs Today (Barc); 2004 Jan; 40(1):29-40. PubMed ID: 14988768
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bisphosphonates in multiple myeloma: a network meta-analysis.
    Mhaskar R; Redzepovic J; Wheatley K; Clark OA; Miladinovic B; Glasmacher A; Kumar A; Djulbegovic B
    Cochrane Database Syst Rev; 2012 May; (5):CD003188. PubMed ID: 22592688
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bisphosphonates in multiple myeloma.
    Djulbegovic B; Wheatley K; Ross J; Clark O; Bos G; Goldschmidt H; Cremer F; Alsina M; Glasmacher A
    Cochrane Database Syst Rev; 2001; (4):CD003188. PubMed ID: 11687178
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bisphosphonates in multiple myeloma.
    Djulbegovic B; Wheatley K; Ross J; Clark O; Bos G; Goldschmidt H; Cremer F; Alsina M; Glasmacher A
    Cochrane Database Syst Rev; 2002; (3):CD003188. PubMed ID: 12137679
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Bisphosphonates in the treatment of multiple myeloma].
    Stajszczyk M
    Przegl Lek; 2002; 59(1):37-42. PubMed ID: 12108045
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Maxilla osseus sequestre and oral exposure: effects of the treatment of multiple myeloma with bisphosphonates.
    Lobato JV; Rodrigues JM; Cavaleiro MV; Lobato JM; Xavier L; Santos JD; Maurício AC
    Acta Med Port; 2007; 20(2):185-92. PubMed ID: 17868526
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical trials of bisphosphonates in multiple myeloma.
    Mahindra A; Pozzi S; Raje N
    Clin Adv Hematol Oncol; 2012 Sep; 10(9):582-7. PubMed ID: 23073123
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Biosphonates in oncology].
    Paule B; Clerc D; Brion N
    Presse Med; 2000 Apr; 29(13):723-9. PubMed ID: 10797827
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bisphosphonate therapy in multiple myeloma.
    Laakso M; Jantunen E
    Acta Oncol; 1996; 35 Suppl 5():55-6. PubMed ID: 9142966
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bisphosphonates in the treatment of malignant bone disease.
    Berenson JR; Lipton A
    Annu Rev Med; 1999; 50():237-48. PubMed ID: 10073275
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bone complications in multiple myeloma.
    Berenson JR; Rajdev L; Broder M
    Cancer Biol Ther; 2006 Sep; 5(9):1082-5. PubMed ID: 16969119
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment for myeloma bone disease.
    Yeh HS; Berenson JR
    Clin Cancer Res; 2006 Oct; 12(20 Pt 2):6279s-6284s. PubMed ID: 17062714
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of pamidronate in reducing skeletal events in patients with advanced multiple myeloma. Myeloma Aredia Study Group.
    Berenson JR; Lichtenstein A; Porter L; Dimopoulos MA; Bordoni R; George S; Lipton A; Keller A; Ballester O; Kovacs MJ; Blacklock HA; Bell R; Simeone J; Reitsma DJ; Heffernan M; Seaman J; Knight RD
    N Engl J Med; 1996 Feb; 334(8):488-93. PubMed ID: 8559201
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The clinical and cost considerations of bisphosphonates in preventing bone complications in patients with metastatic breast cancer or multiple myeloma.
    McCloskey EV; Guest JF; Kanis JA
    Drugs; 2001; 61(9):1253-74. PubMed ID: 11511021
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bisphosphonates for breast cancer.
    Pavlakis N; Stockler M
    Cochrane Database Syst Rev; 2002; (1):CD003474. PubMed ID: 11869664
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of bisphosphonates in the treatment of bone metastases--the U.S. experience.
    Harvey HA; Lipton A
    Support Care Cancer; 1996 May; 4(3):213-7. PubMed ID: 8739655
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of bisphosphonates in patients with metastatic bone disease.
    Berenson JR; Lipton A
    Oncology (Williston Park); 1998 Nov; 12(11):1573-9; discussion 1579-81. PubMed ID: 9834935
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bisphosphonate therapy in multiple myeloma: past, present, future.
    Jantunen E
    Eur J Haematol; 2002; 69(5-6):257-64. PubMed ID: 12460229
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The use of bisphosphonates in patients with breast cancer.
    Van Poznak CH
    Cancer Control; 2002; 9(6):480-9. PubMed ID: 12514566
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of long-term intravenous ibandronate therapy on skeletal-related events, survival, and bone resorption markers in patients with advanced multiple myeloma.
    Menssen HD; Sakalová A; Fontana A; Herrmann Z; Boewer C; Facon T; Lichinitser MR; Singer CR; Euller-Ziegler L; Wetterwald M; Fiere D; Hrubisko M; Thiel E; Delmas PD
    J Clin Oncol; 2002 May; 20(9):2353-9. PubMed ID: 11981007
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.